| 1 |
9874563 |
The HIV-1 virion-associated protein vpr is a coactivator of the human glucocorticoid receptor |
Mutation
|
| 2 |
17958917 |
Functional relevance of nonsynonymous mutations in the HIV-1 tat gene within an epidemiologically-linked transmission cohort |
Mutation
|
| 3 |
27231099 |
Treatment failure and drug resistance in HIV-positive patients on tenofovir-based first-line antiretroviral therapy in western Kenya |
Mutation
|
| 4 |
17194486 |
Drug-resistant HIV-1 prevalence in patients newly diagnosed with HIV/AIDS in Japan |
Mutation
|
| 5 |
18052601 |
N348I in the connection domain of HIV-1 reverse transcriptase confers zidovudine and nevirapine resistance |
Mutation
|
| 6 |
28099515 |
Polymorphisms and Mutational Covariation Associated with Death in a Prospective Cohort of HIV/AIDS Patients Receiving Long-Term ART in China |
Mutation
|
| 7 |
29698467 |
HIV-1 genetic transmission networks among men who have sex with men in Kunming, China |
Mutation
|
| 8 |
30061964 |
Antiretroviral resistance among HIV-1 patients on first-line therapy attending a comprehensive care clinic in Kenyatta National Hospital, Kenya: a retrospective analysis |
Mutation
|
| 9 |
30442114 |
Research on the treatment effects and drug resistances of long-term second-line antiretroviral therapy among HIV-infected patients from Henan Province in China |
Mutation
|
| 10 |
31190911 |
Antiretroviral drug resistance mutations among patients failing first-line treatment in Hanoi, Vietnam |
Mutation
|
| 11 |
31574109 |
Major drug resistance mutations to HIV-1 protease inhibitors (PI) among patients exposed to PI class failing antiretroviral therapy in Sao Paulo State, Brazil |
Mutation
|
| 12 |
31767136 |
Indazolyl-substituted piperidin-4-yl-aminopyrimidines as HIV-1 NNRTIs: Design, synthesis and biological activities |
Mutation
|
| 13 |
31920003 |
Highly drug-resistant HIV-1 protease reveals decreased intra-subunit interactions due to clusters of mutations |
Mutation
|
| 14 |
32218587 |
Characterization of HIV-1 genetic diversity and antiretroviral resistance in the state of Maranhao, Northeast Brazil |
Mutation
|
| 15 |
32280691 |
HIV-1 Drug Resistance, Distribution of Subtypes, and Drug Resistance-Associated Mutations in Virologic Failure Individuals in Chengdu, Southwest China, 2014-2016 |
Mutation
|
| 16 |
32295123 |
Molecular Epidemiology of the HIV-1 Subtype B Sub-Epidemic in Bulgaria |
Mutation
|
| 17 |
32368103 |
HIV-1 Drug Resistance in ART-Naive Individuals in Myanmar |
Mutation
|
| 18 |
32381145 |
The characteristics of pretreatment HIV-1 drug resistance in western Yunnan, China |
Mutation
|
| 19 |
32994325 |
CPSF6-Dependent Targeting of Speckle-Associated Domains Distinguishes Primate from Nonprimate Lentiviral Integration |
Mutation
|
| 20 |
33143751 |
Predictors of first-line antiretroviral therapy failure among adults and adolescents living with HIV/AIDS in a large prevention and treatment program in Nigeria |
Mutation
|
| 21 |
33692637 |
First-Line Antiretroviral Regimen Failure and Determinants in an Urban HIV Clinic at Phramongkutklao Hospital, Bangkok, Thailand: 20 Years Experience |
Mutation
|
| 22 |
40106654 |
Mutations associated with viral resistance to integrase in individuals initiating dolutegravir-containing antiretroviral therapy: retrospective cohort, Brazil 2017-2019 |
Mutation
|
| 23 |
40146807 |
Cabotegravir/rilpivirine resistance in a patient living with HIV despite on-time administration: A case report |
Mutation
|
| 24 |
30538178 |
Structural Constraints at the Trimer Apex Stabilize the HIV-1 Envelope in a Closed, Antibody-Protected Conformation |
Mutation
|
| 25 |
30863788 |
Persistence of Human Immunodeficiency Virus-1 Drug Resistance Mutations in Proviral Deoxyribonucleic Acid After Virologic Failure of Efavirenz-Containing Antiretroviral Regimens |
Mutation
|
| 26 |
31370888 |
The urgent need for more potent antiretroviral therapy in low-income countries to achieve UNAIDS 90-90-90 and complete eradication of AIDS by 2030 |
Mutation
|
| 27 |
31774915 |
New Perspectives on the Virologic Consequences of M184V or I in Human Immunodeficiency Virus-1 Reverse Transcriptase |
Mutation
|
| 28 |
32001525 |
Structural basis of second-generation HIV integrase inhibitor action and viral resistance |
Mutation
|
| 29 |
20102271 |
Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure |
Mutation
|
| 30 |
32082978 |
Improving the positional adaptability: structure-based design of biphenyl-substituted diaryltriazines as novel non-nucleoside HIV-1 reverse transcriptase inhibitors |
Mutation
|
| 31 |
32111013 |
Design of Biphenyl-Substituted Diarylpyrimidines with a Cyanomethyl Linker as HIV-1 NNRTIs via a Molecular Hybridization Strategy |
Mutation
|
| 32 |
32140396 |
Synthesis and biological evaluation of a series of 2-(((5-akly/aryl-1H-pyrazol-3-yl)methyl)thio)-5-alkyl-6-(cyclohexylmethyl)-pyrimidin-4(3H)-ones as potential HIV-1 inhibitors |
Mutation
|
| 33 |
32478251 |
Visualizing Tetrahedral Oxyanion Bound in HIV-1 Protease Using Neutrons: Implications for the Catalytic Mechanism and Drug Design |
Mutation
|
| 34 |
32665270 |
Convergent Evolution of HLA-C Downmodulation in HIV-1 and HIV-2 |
Mutation
|
| 35 |
32873191 |
HIV-1 resists MxB inhibition of viral Rev protein |
Mutation
|
| 36 |
32977702 |
Identification of Modulators of HIV-1 Proviral Transcription from a Library of FDA-Approved Pharmaceuticals |
Mutation
|
| 37 |
33095511 |
Characterization of New DNA Aptamers for Anti-HIV-1 Reverse Transcriptase |
Mutation
|
| 38 |
33109760 |
HIV-1 Nef Interacts with LMP7 To Attenuate Immunoproteasome Formation and Major Histocompatibility Complex Class I Antigen Presentation |
Mutation
|
| 39 |
33437166 |
The frequency of defective genes in vif and vpr genes in 20 hemophiliacs is associated with Korean Red Ginseng and highly active antiretroviral therapy: the impact of lethal mutations in vif and vpr genes on HIV-1 evolution |
Mutation
|
| 40 |
33635848 |
Drug resistance mutations in HIV provirus are associated with defective proviral genomes with hypermutation |
Mutation
|
| 41 |
33758083 |
Cytoplasmic CPSF6 Regulates HIV-1 Capsid Trafficking and Infection in a Cyclophilin A-Dependent Manner |
Mutation
|
| 42 |
33811831 |
The SMC5/6 complex compacts and silences unintegrated HIV-1 DNA and is antagonized by Vpr |
Mutation
|
| 43 |
33883222 |
Species-Specific Valid Ternary Interactions of HIV-1 Env-gp120, CD4, and CCR5 as Revealed by an Adaptive Single-Amino Acid Substitution at the V3 Loop Tip |
Mutation
|
| 44 |
33895602 |
Chemical space exploration of novel naphthyl-carboxamide-diarylpyrimidine derivatives with potent anti-HIV-1 activity |
Mutation
|
| 45 |
33965042 |
Near-point-of-care assay with a visual readout for detection of HIV-1 drug resistance mutations: A proof-of-concept study |
Mutation
|
| 46 |
34708015 |
Prevalence and Molecular Epidemiology of Transmitted Drug Resistance and Genetic Transmission Networks Among Newly Diagnosed People Living With HIV/AIDS in a Minority Area, China |
Mutation
|
| 47 |
38847281 |
Virologic Failure and Drug Resistance After Programmatic Switching to Dolutegravir-based First-line Antiretroviral Therapy in Malawi and Zambia |
Mutation
|
| 48 |
39507954 |
[Analysis of HIV-1 Subtypes and Transmitted Drug Resistance in Hospitalized Treatment-Native Patients With AIDS] |
Mutation
|
| 49 |
39741997 |
Novel Dolutegravir and Lenacapavir Resistance Patterns in Human Immunodeficiency Virus Type 2 Infection: A Case Report |
Mutation
|
| 50 |
20102272 |
Low frequency nonnucleoside reverse-transcriptase inhibitor-resistant variants contribute to failure of efavirenz-containing regimens in treatment- experienced patients |
Mutation
|
| 51 |
27119150 |
HIV-1 Antiretroviral Drug Resistance Mutations in Treatment Naive and Experienced Panamanian Subjects: Impact on National Use of EFV-Based Schemes |
Mutation
|